Literature DB >> 11755332

Effects of the incorporation of IBTM beta-turn mimetics into the dipeptoid CCK(1) receptor agonist PD 170292.

Mercedes Martín-Martínez1, Miriam Latorre, M Teresa García-López, Edurne Cenarruzabeitia, Joaquín Del Río, Rosario González-Muñiz.   

Abstract

Replacement of the 2-Adoc-D-alphaMeTrp residue in the non-selective CCK(1) receptor agonist PD 170292 by the Z-(2R,5R,11bS)-IBTM skeleton, able to fix a type II beta-turn-like conformation, led to a conformationally restricted dipeptoid analogue, namely 3a, which exhibited a notable increase in the CCK(1) selectivity and antagonist properties.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11755332     DOI: 10.1016/s0960-894x(01)00630-8

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

Review 1.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

2.  New tetracyclic tetrahydro-beta-carbolines as tryptophan-derived peptidomimetics.

Authors:  Karolina Pulka; Debby Feytens; Aleksandra Misicka; Dirk Tourwé
Journal:  Mol Divers       Date:  2009-06-16       Impact factor: 2.943

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.